Clinical Trial Update: The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland

View source ↗

Summary

An observational study in Ireland assessing the effectiveness of ABT-450/r (ombitasvir) ± dasabuvir ± ribavirin for chronic hepatitis C; study status completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-450/r (paritaprevir/ritonavir)
• Dasabuvir (dasabuvir)
• Ribavirin (ribavirin)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C | Status: COMPLETED | Results posted: 2019-05-06